Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Sales | 606 | 849 | 422 | 1,190 | 1,770 |
| Cost of Goods | 109 | 26 | 3 | 535 | 960 |
| Gross Profit | 496 | 823 | 420 | 654 | 810 |
| Operating Expenses | 1,997 | 1,469 | 700 | 4,060 | 2,910 |
| Operating Income | -1,392 | -620 | -278 | -2,870 | -1,140 |
| Interest Expense | 258 | 19 | 1 | 58 | 30 |
| Other Income | 346 | 1 | 0 | 156 | 0 |
| Pre-tax Income | -1,303 | -638 | -279 | -2,772 | -1,170 |
| Income Tax | N/A | -330 | 1,595 | N/A | 0 |
| Net Income Continuous | -1,303 | -308 | -1,874 | -2,772 | -1,176 |
| Net Income Discontinuous | N/A | 524 | -2,537 | N/A | 0 |
| Net Income | $-1,303 | $216 | $-4,410 | $-2,772 | $-1,170 |
| EPS Basic Total Ops | -2.10 | 0.28 | -5.04 | -3.92 | -0.42 |
| EPS Basic Continuous Ops | -1.47 | -0.28 | -2.10 | -3.91 | -0.49 |
| EPS Basic Discontinuous Ops | N/A | 0.56 | -2.94 | N/A | N/A |
| EPS Diluted Total Ops | -2.10 | 0.28 | -5.04 | -3.92 | -0.42 |
| EPS Diluted Continuous Ops | -1.47 | -0.28 | -2.10 | -3.91 | -0.49 |
| EPS Diluted Discontinuous Ops | N/A | 0.56 | -2.94 | N/A | N/A |
| EBITDA(a) | $-1,140 | $-451 | $-267 | $-2,604 | $-860 |